Eli Glatstein

Active 1969–2020

Also published as
ELI GLATSTEIN
107
Papers
21,759
Citations
90
h-index
107
i10-index

Citations

Citations per year for Eli Glatstein1970: 3 citations1971: 11 citations1972: 7 citations1973: 9 citations1974: 7 citations1975: 6 citations1976: 12 citations1977: 8 citations1978: 27 citations1979: 22 citations1980: 32 citations1981: 30 citations1982: 27 citations1983: 27 citations1984: 46 citations1985: 63 citations1986: 54 citations1987: 49 citations1988: 75 citations1989: 48 citations1990: 70 citations1991: 82 citations1992: 72 citations1993: 80 citations1994: 77 citations1995: 113 citations1996: 105 citations1997: 70 citations1998: 78 citations1999: 101 citations2000: 109 citations2001: 118 citations2002: 135 citations2003: 149 citations2004: 131 citations2005: 121 citations2006: 128 citations2007: 117 citations2008: 105 citations2009: 104 citations2010: 122 citations2011: 80 citations2012: 98 citations2013: 70 citations2014: 77 citations2015: 62 citations2016: 53 citations2017: 59 citations2018: 48 citations2019: 188 citations2020: 218 citations2021: 185 citations2022: 127 citations2023: 72 citations2024: 166 citations2025: 40 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,930 citing papers, 40.6% of this breakdownUnited Kingdom: 283 citing papers, 5.9% of this breakdownCanada: 229 citing papers, 4.8% of this breakdownItaly: 229 citing papers, 4.8% of this breakdownFrance: 214 citing papers, 4.5% of this breakdownNetherlands: 214 citing papers, 4.5% of this breakdownGermany: 208 citing papers, 4.4% of this breakdownChina: 168 citing papers, 3.5% of this breakdownAustralia: 104 citing papers, 2.2% of this breakdownJapan: 99 citing papers, 2.1% of this breakdownSwitzerland: 82 citing papers, 1.7% of this breakdownSpain: 71 citing papers, 1.5% of this breakdown
0%40.6%Other 19.5%

Fields

  • Medicine81.4%
  • Biochemistry, Genetics and Molecular Biology8.9%
  • Engineering2.9%
  • Physics and Astronomy2.6%
  • Neuroscience1.3%
  • Immunology and Microbiology0.6%
  • Other2.3%

Topics

  • Sarcoma Diagnosis and Treatment6.6%
  • Lymphoma Diagnosis and Treatment6.4%
  • Photodynamic Therapy Research Studies3.2%
  • Nanoplatforms for cancer theranostics2.9%
  • Vascular Tumors and Angiosarcomas2.5%
  • Lung Cancer Research Studies2%
  • Other76.4%

Coauthors

All papers

Open in search
  1. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 1998 cited by 1,531

  2. The Treatment of Soft-tissue Sarcomas of the Extremities

    Authors: , , , , , , , , , , - Annals of Surgery 1982 cited by 1,350

  3. Understanding High-Dose, Ultra-High Dose Rate, and Spatially Fractionated Radiation Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Catherine Vozenin, May Abdel–Wahab, James S. Welsh, Xiaodong Wu, Charles L. Limoli - International Journal of Radiation Oncology*Biology*Physics 2020 cited by 126

  4. Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death

    Authors: , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2019 cited by 187

  5. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.

    Authors: , , , , , , , , - Journal of Clinical Oncology 1989 cited by 1,628

  6. Extended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years

    Authors: , , , , , , , , , , - The Annals of Thoracic Surgery 2016 cited by 123

  7. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy.

    Authors: , , , - Journal of Clinical Oncology 1994 cited by 724

  8. Short-Term and Long-Term Health Risks of Nuclear-Power-Plant Accidents

    Authors: , , , , , - New England Journal of Medicine 2011 cited by 186

  9. Multi‐institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity

    Authors: , , , , , , , , , , , , , , , , , - Journal of Surgical Oncology 2020 cited by 43

  10. Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer

    Authors: , , , , , , , , , - New England Journal of Medicine 1995 cited by 901

  11. Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy

    Authors: , , , , , , , , , - Clinical Cancer Research 2005 cited by 234

  12. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors

    Authors: , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1993 cited by 157

  13. A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy

    Authors: , , , , , , , - Clinical Cancer Research 2004 cited by 148

  14. Photodynamic therapy for the treatment of non-small cell lung cancer.

    Authors: , , , , , , - 2012 cited by 105

  15. A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis Fungoides

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 1989 cited by 492

  16. The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.

    Authors: , , , , , - 1988 cited by 313

  17. Tempol, a stable free radical, is a novel murine radiation protector.

    Authors: , , , , , , , , , - 1992 cited by 212

  18. Radical Pleurectomy and Intraoperative Photodynamic Therapy for Malignant Pleural Mesothelioma

    Authors: , , , , , , , , - The Annals of Thoracic Surgery 2012 cited by 148

  19. A Phase II Trial of Intraperitoneal Photodynamic Therapy for Patients with Peritoneal Carcinomatosis and Sarcomatosis

    Authors: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2006 cited by 116

  20. Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy

    Authors: , , , , , , , , , , - Journal of Biomedical Optics 2005 cited by 116

  21. Phase II Trial of Pleural Photodynamic Therapy and Surgery for Patients With Non–Small-Cell Lung Cancer With Pleural Spread

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2004 cited by 115

  22. Phase II Trial of Debulking Surgery and Photodynamic Therapy for Disseminated Intraperitoneal Tumors

    Authors: , , , , , , , - Annals of Surgical Oncology 2001 cited by 111

  23. Photofrin Uptake in the Tumor and Normal Tissues of Patients Receiving Intraperitoneal Photodynamic Therapy

    Authors: , , , , , , , , , - Clinical Cancer Research 2006 cited by 93

  24. TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions

    Authors: , , , - Bone Marrow Transplantation 2010 cited by 83